{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:39:15Z","timestamp":1787002755348,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Erythromelalgia is a rare, chronic pain disorder characterized by the triad of intense burning sensation, warmth, and redness, primarily involving the hands and feet, and usually alleviated by cold and worsened by heat. The objective of this scoping review was to: 1) map the existing literature on erythromelalgia in youth, 2) identify knowledge gaps, and 3) inform directions for future research in pediatric erythromelalgia. One hundred and sixty-seven studies reporting 411 cases of childhood-onset erythromelalgia were identified. Variability was found in reporting of clinical symptoms, the clinical presentations and diagnostic criteria used for classification of erythromelagia, the clinical assessments and investigations performed, and the types of interventions and management plans utilised. While factors to aid early recognition and optimize management have been identified, there are also significant gaps for future research to address. Ongoing efforts to develop a multicenter registry of pediatric erythromelalgia cases, with standardized data collection and reporting, will be beneficial to establish consensus recommendations for the diagnosis and management of pediatric erythromelalgia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>This scoping review maps the existing literature on pediatric erythromelalgia.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Variability was found in reporting of clinical symptoms, the clinical presentations and diagnostic criteria used for classification of erythromelagia, the clinical assessments and investigations performed, and the types of interventions and management plans utilised.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The development of an international registry would immensely benefit multidisciplinary experts involved in the care of pediatric erythromelalgia and those with lived experience.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-03817-4","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:47:16Z","timestamp":1737024436000},"page":"786-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pediatric erythromelalgia from multidisciplinary perspectives: a scoping review"],"prefix":"10.1038","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4265-8647","authenticated-orcid":false,"given":"Don Daniel","family":"Ocay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Graziano Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Brownstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui","family":"Clinch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn Marie","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"De Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Donado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Halpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Kattail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Howard","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Ravetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sandroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See Wan","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Walco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suellen M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Berde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"3817_CR1","doi-asserted-by":"crossref","unstructured":"Mitchell, S. W. On a Rare Vaso-Motor Neurosis of the Extremities, and on the Maladies with Which It May Be Confounded ([publisher not identified], 1878).","DOI":"10.1097\/00000441-187815100-00001"},{"key":"3817_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00000441-193204000-00005","volume":"183","author":"GE Brown","year":"1932","unstructured":"Brown, G. E. Erythromelalgia and other disturbances of the extremities accompanied by vasodilatation and burning. Am. J. Med. Sci. 183, 12 (1932).","journal-title":"Am. J. Med. Sci."},{"key":"3817_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0002-8703(38)90693-3","volume":"16","author":"LA Smith","year":"1938","unstructured":"Smith, L. A. & Allen, E. V. Erythermalgia (erythromelalgia) of the extremities - a syndrome characterized by redness, heat, and pain. Am. Heart J. 16, 175\u2013188 (1938).","journal-title":"Am. Heart J."},{"key":"3817_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-4362.1994.tb04037.x","volume":"33","author":"JP Drenth","year":"1994","unstructured":"Drenth, J. P. & Michiels, J. J. Erythromelalgia and erythermalgia: diagnostic differentiation. Int. J. Dermatol 33, 393\u2013397 (1994).","journal-title":"Int. J. Dermatol"},{"key":"3817_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jpeds.2018.10.024","volume":"206","author":"L Arthur","year":"2019","unstructured":"Arthur, L. et al. Pediatric erythromelalgia and Scn9a mutations: systematic review and single-center case series. J. Pediatr. 206, 217\u2013224 e219 (2019).","journal-title":"J. Pediatr."},{"key":"3817_CR6","first-page":"80","volume":"35","author":"LK Parker","year":"2017","unstructured":"Parker, L. K. et al. Clinical features and management of erythromelalgia: long term follow-up of 46 cases. Clin. Exp. Rheumatol. 35, 80\u201384 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"3817_CR7","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2147\/JPR.S154462","volume":"11","author":"SW Tham","year":"2018","unstructured":"Tham, S. W. & Giles, M. Current pain management strategies for patients with erythromelalgia: a critical review. J. Pain. Res. 11, 1689\u20131698 (2018).","journal-title":"J. Pain. Res."},{"key":"3817_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/children10081282","volume":"10","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. Clinical characterization of pediatric erythromelalgia: a single-center case series. Children 10, 1282 (2023).","journal-title":"Children"},{"key":"3817_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1024\/0301-1526\/a000162","volume":"41","author":"A Alhadad","year":"2012","unstructured":"Alhadad, A., Wollmer, P., Svensson, A. & Eriksson, K. F. Erythromelalgia: incidence and clinical experience in a single centre in Sweden. Vasa 41, 43\u201348 (2012).","journal-title":"Vasa"},{"key":"3817_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1468-3083.2008.02938.x","volume":"23","author":"KB Reed","year":"2009","unstructured":"Reed, K. B. & Davis, M. D. Incidence of erythromelalgia: a population-based study in Olmsted County, Minnesota. J. Eur. Acad. Dermatol Venereol. 23, 13\u201315 (2009).","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"3817_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jaad.2011.01.010","volume":"66","author":"RH Cook-Norris","year":"2012","unstructured":"Cook-Norris, R. H. et al. Pediatric erythromelalgia: a retrospective review of 32 cases evaluated at mayo clinic over a 37-year period. J. Am. Acad. Dermatol 66, 416\u2013423 (2012).","journal-title":"J. Am. Acad. Dermatol"},{"key":"3817_CR12","doi-asserted-by":"crossref","unstructured":"Caldito, E. G., Caldito, N. G., Kaul, S., Piette, W. & Mehta, S. Erythromelalgia. Part II: Differential Diagnoses and Management. J. Am. Acad. Dermatol. 90, 465-474 (2024).","DOI":"10.1016\/j.jaad.2023.02.070"},{"key":"3817_CR13","doi-asserted-by":"crossref","unstructured":"Caldito, E. G., Kaul, S., Caldito, N. G., Piette, W. & Mehta, S. Erythromelalgia. Part I: Pathogenesis, Clinical Features, Evaluation, and Complications. J. Am. Acad. Dermatol. 90, 453\u2013462 (2023).","DOI":"10.1016\/j.jaad.2023.02.071"},{"key":"3817_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco, A. C. et al. Prisma extension for scoping reviews (Prisma-Scr): checklist and explanation. Ann. Intern Med 169, 467\u2013473 (2018).","journal-title":"Ann. Intern Med"},{"key":"3817_CR15","unstructured":"Ocay, D. D. et al. Pediatric Erythromelalgia from Multidisciplinary Perspectives: A Scoping Review Protocol. OSF (2023)."},{"key":"3817_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jmg.2003.012153","volume":"41","author":"Y Yang","year":"2004","unstructured":"Yang, Y. et al. Mutations in Scn9a, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41, 171\u2013174 (2004).","journal-title":"J. Med. Genet."},{"key":"3817_CR17","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/j.pain.0000000000000229","volume":"156","author":"B Namer","year":"2015","unstructured":"Namer, B. et al. Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848t gain-of-function mutation of Nav1.7. Pain 156, 1637\u20131646 (2015).","journal-title":"Pain"},{"key":"3817_CR18","doi-asserted-by":"publisher","first-page":"335ra356","DOI":"10.1126\/scitranslmed.aad7653","volume":"8","author":"L Cao","year":"2016","unstructured":"Cao, L. et al. Pharmacological reversal of a pain phenotype in Ipsc-derived sensory neurons and patients with inherited erythromelalgia. Sci. Transl. Med 8, 335ra356 (2016).","journal-title":"Sci. Transl. Med"},{"key":"3817_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pain.2011.09.008","volume":"153","author":"YP Goldberg","year":"2012","unstructured":"Goldberg, Y. P. et al. Treatment of Na(V)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker. Pain 153, 80\u201385 (2012).","journal-title":"Pain"},{"key":"3817_CR20","unstructured":"AlgoTherapeutix. A Randomized, Double-Blind, Placebo-Controlled, 2-Period, Crossover Study to Evaluate the Efficacy and Safety of Atx01 (Topical Amitriptyline Hydrochloride 15% W\/W) in Adult Patients with Pain Due to Erythromelalgia (Em), https:\/\/clinicaltrials.gov\/study\/NCT05917912 (2023)."},{"key":"3817_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.mayocp.2022.08.005","volume":"98","author":"JE Ma","year":"2023","unstructured":"Ma, J. E. et al. Erythromelalgia: a review of medical management options and our approach to management. Mayo Clin. Proc. 98, 136\u2013149 (2023).","journal-title":"Mayo Clin. Proc."},{"key":"3817_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5315\/wjh.v6.i3.32","volume":"6","author":"JJ Michiels","year":"2017","unstructured":"Michiels, J. J. Aspirin cures erythromelalgia and cerebrovascular disturbances in Jak2-thrombocythemia through platelet-cycloxygenase inhibition. WJH 6, 32\u201354 (2017).","journal-title":"WJH"},{"key":"3817_CR23","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/bph.13935","volume":"175","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Nav1.7 mutation I234t. Br. J. Pharmacol. 175, 2261\u20132271 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"3817_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ana.21678","volume":"65","author":"TZ Fischer","year":"2009","unstructured":"Fischer, T. Z. et al. A Novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia. Ann. Neurol. 65, 733\u2013741 (2009).","journal-title":"Ann. Neurol."},{"key":"3817_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.expneurol.2008.12.012","volume":"216","author":"JS Choi","year":"2009","unstructured":"Choi, J. S. et al. Mexiletine-Responsive Erythromelalgia Due to a New Na(V)1.7 Mutation Showing Use-Dependent Current Fall-Off. Exp. Neurol. 216, 383\u2013389 (2009).","journal-title":"Exp. Neurol."},{"key":"3817_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pain.2009.07.025","volume":"145","author":"D Naleschinski","year":"2009","unstructured":"Naleschinski, D., Arning, K. & Baron, R. Fabry disease-pain doctors have to find the missing ones. Pain 145, 10\u201311 (2009).","journal-title":"Pain"},{"key":"3817_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2009.06.032","volume":"145","author":"A Torvin M\u00f8ller","year":"2009","unstructured":"Torvin M\u00f8ller, A. et al. Functional and structural nerve fiber findings in heterozygote patients with fabry disease. Pain 145, 237\u2013245 (2009).","journal-title":"Pain"},{"key":"3817_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00131402-199912000-00001","volume":"1","author":"P Sandroni","year":"1999","unstructured":"Sandroni, P. et al. Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J. Clin. Neuromuscul. Dis. 1, 57\u201363 (1999).","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"3817_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archderm.136.3.330","volume":"136","author":"MD Davis","year":"2000","unstructured":"Davis, M. D., O\u2019Fallon, W. M., Rogers, R. S. 3rd & Rooke, T. W. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch. Dermatol 136, 330\u2013336 (2000).","journal-title":"Arch. Dermatol"},{"key":"3817_CR30","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/ajh.26008","volume":"95","author":"A Tefferi","year":"2020","unstructured":"Tefferi, A. & Barbui, T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am. J. Hematol. 95, 1599\u20131613 (2020).","journal-title":"Am. J. Hematol."},{"key":"3817_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1542\/peds.2005-0697","volume":"116","author":"A Oaklander","year":"2005","unstructured":"Oaklander, A. Erythromelalgia: small-fiber neuropathy by any other name? Pediatrics 116, 293\u2013294 (2005). author reply 294\u2013295.","journal-title":"Pediatrics"},{"key":"3817_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1213\/01.ane.0000252965.83347.25","volume":"104","author":"J Paticoff","year":"2007","unstructured":"Paticoff, J., Valovska, A., Nedeljkovic, S. S. & Oaklander, A. L. Defining a treatable cause of erythromelalgia: acute adolescent autoimmune small-fiber axonopathy. Anesth. Analg. 104, 438\u2013441 (2007).","journal-title":"Anesth. Analg."},{"key":"3817_CR33","unstructured":"Kuroda, T., Sugimoto, A., Ishigaki, S., Murakami, H. & Kawamura, M. A case of primary erythromelalgia successfully treated with high-dose intravenous immunoglobulin therapy. Brain Nerve 66, 185\u2013189 (2014)."},{"key":"3817_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","volume":"15","author":"G Lauria","year":"2010","unstructured":"Lauria, G. et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J. Peripher Nerv. Syst. 15, 202\u2013207 (2010).","journal-title":"J. Peripher Nerv. Syst."},{"key":"3817_CR35","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archneur.55.12.1513","volume":"55","author":"JC McArthur","year":"1998","unstructured":"McArthur, J. C., Stocks, E. A., Hauer, P., Cornblath, D. R. & Griffin, J. W. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch. Neurol. 55, 1513\u20131520 (1998).","journal-title":"Arch. Neurol."},{"key":"3817_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/mus.24329","volume":"51","author":"IG Panoutsopoulou","year":"2015","unstructured":"Panoutsopoulou, I. G., Luciano, C. A., Wendelschafer-Crabb, G., Hodges, J. S. & Kennedy, W. R. Epidermal innervation in healthy children and adolescents. Muscle Nerve 51, 378\u2013384 (2015).","journal-title":"Muscle Nerve"},{"key":"3817_CR37","doi-asserted-by":"publisher","first-page":"e2534","DOI":"10.1212\/WNL.0000000000011919","volume":"96","author":"M Geerts","year":"2021","unstructured":"Geerts, M. et al. Intravenous immunoglobulin therapy in patients with painful idiopathic small fiber neuropathy. Neurology 96, e2534\u2013e2545 (2021).","journal-title":"Neurology"},{"key":"3817_CR38","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1093\/brain\/awad328","volume":"146","author":"A Lischka","year":"2023","unstructured":"Lischka, A. et al. Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies. Brain 146, 4880\u20134890 (2023).","journal-title":"Brain"},{"key":"3817_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41876-5","volume":"14","author":"S Hartmann","year":"2023","unstructured":"Hartmann, S. et al. Adra2a and Irx1 are putative risk genes for Raynaud\u2019s phenomenon. Nat. Commun. 14, 6156 (2023).","journal-title":"Nat. Commun."},{"key":"3817_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmg-2023-109236","volume":"61","author":"SS Shaikh","year":"2024","unstructured":"Shaikh, S. S. et al. Evidence of a genetic background predisposing to complex regional pain syndrome type 1. J. Med Genet 61, 163\u2013170 (2024).","journal-title":"J. Med Genet"},{"key":"3817_CR41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuron.2010.04.030","volume":"66","author":"B Kremeyer","year":"2010","unstructured":"Kremeyer, B. et al. A gain-of-function mutation in Trpa1 causes familial episodic pain syndrome. Neuron 66, 671\u2013680 (2010).","journal-title":"Neuron"},{"key":"3817_CR42","unstructured":"Jha, S. K., Karna, B. & Goodman, M. B. In Statpearls (2022)."},{"key":"3817_CR43","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2147\/JPR.S388896","volume":"16","author":"A Dormer","year":"2023","unstructured":"Dormer, A. et al. A review of the therapeutic targeting of Scn9a and Nav1.7 for pain relief in current human clinical trials. J. Pain. Res. 16, 1487\u20131498 (2023).","journal-title":"J. Pain. Res."},{"key":"3817_CR44","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/j.pain.0000000000001609","volume":"160","author":"C Eccleston","year":"2019","unstructured":"Eccleston, C. et al. Pharmacological interventions for chronic pain in children: an overview of systematic reviews. Pain 160, 1698\u20131707 (2019).","journal-title":"Pain"},{"key":"3817_CR45","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","volume":"156","author":"R-D Treede","year":"2015","unstructured":"Treede, R.-D. et al. A classification of chronic pain for Icd-11. Pain 156, 1003\u20131007 (2015).","journal-title":"Pain"},{"key":"3817_CR46","doi-asserted-by":"crossref","unstructured":"Vinall, J., Pavlova, M., Asmundson, G. J., Rasic, N. & Noel, M. Mental health comorbidities in pediatric chronic pain: a narrative review of epidemiology, models, neurobiological mechanisms and treatment. Children (Basel) 3, 40 (2016).","DOI":"10.3390\/children3040040"},{"key":"3817_CR47","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/j.pain.0000000000003105","volume":"165","author":"TM Palermo","year":"2024","unstructured":"Palermo, T. M. et al. Updated recommendations on measures for clinical trials in pediatric chronic pain: a multiphase approach from the core outcomes in pediatric persistent pain (Core-Oppp) Workgroup. Pain 165, 1086\u20131100 (2024).","journal-title":"Pain"},{"key":"3817_CR48","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1097\/j.pain.0000000000000602","volume":"157","author":"RR Edwards","year":"2016","unstructured":"Edwards, R. R. et al. Patient phenotyping in clinical trials of chronic pain treatments: immpact recommendations. Pain 157, 1851\u20131871 (2016).","journal-title":"Pain"},{"key":"3817_CR49","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/j.pain.0000000000002998","volume":"165","author":"R Li","year":"2024","unstructured":"Li, R., Gibler, R. C., Rheel, E., Slack, K. & Palermo, T. M. Recommendations for patient-reported outcomes measurement information system pediatric measures in youth with chronic pain: a consensus-based standards for the selection of health measurement instruments systematic review of measurement properties. Pain 165, 258\u2013295 (2024).","journal-title":"Pain"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03817-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:07:55Z","timestamp":1759914475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03817-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-03817-4","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}